Viridans-group streptococcal infections in immunocompromised hosts
- 13 March 2000
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 14 (2) , 129-135
- https://doi.org/10.1016/s0924-8579(99)00172-7
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Viridans streptococcal bacteraemia in patients with neutropeniaThe Lancet, 1995
- Pre-emptive administration of corticosteroids prevents the development of ARDS associated withStreptococcus mitis bacteremia following chemotherapy with high-dose cytarabineAnnals of Hematology, 1994
- Alpha-Streptococci as Supplementary Treatment of Recurrent Streptococcal Tonsillitis: A randomized Placebo-controlled StudyScandinavian Journal of Infectious Diseases, 1993
- Viridans streptococcal bacteraemia in patients with haematological and solid malignanciesEuropean Journal of Cancer and Clinical Oncology, 1991
- Septicemia due toStreptococcus mitis in neutropenic patients with acute leukemiaAnnals of Hematology, 1990
- Vancomycin, Ticarcillin, and Amikacin Compared with Ticarcillin-Clavulanate and Amikacin in the Empirical Treatment of Febrile, Neutropenic Children with CancerNew England Journal of Medicine, 1988
- Interference by an ?-hemolytic streptococcus of ?-hemolytic pathogenic streptococciInflammation, 1979
- Endocarditis Due to Resistant Viridans Streptococci during Oral Penicillin ChemoprophylaxisNew England Journal of Medicine, 1979
- Streptococcus salivarius sepsisin children with malignanciesThe Journal of Pediatrics, 1978
- Alpha-hemolytic streptococci: Clinical significance in the cancer patientMedical and Pediatric Oncology, 1978